Crescent CLO Suddenly Liquidated, B-Tranche Investors Wiped Out
nashnova research
A $510 million CLO managed by Crescent Capital was suddenly liquidated, leaving B-rated noteholders with zero recovery; some of the same loans were later bought back by other Crescent-managed vehicles, raising conflict-of-interest questions.
How was this CLO "legally dismantled"?
In June, Crescent bulk-tagged most loans in its Atlas Senior Loan Fund X — a CLO, meaning a vehicle that bundles corporate loans into layered bonds sold to different investors — as "credit risk" assets.
This means → the manager gained broader authority to sell, without approval from subordinate noteholders, shrinking the portfolio below a 20% threshold that triggers mandatory liquidation.
In plain terms = the trust deed contained a mechanism: once the manager labels enough loans as "risky," it can bypass junior investors, sell the assets, and shut the fund down. Contractually legal — but junior investors had no say.
Who lost money, and how much?
Per the September trustee report, B-rated noteholders suffered a total loss. BB-rated notes also took impairments.
Equity-tranche investors — last in the cash-flow waterfall — have received no distributions since July 2025.
This reflects the brutal reality of CLO "waterfall" structures in stress: senior bonds absorb cash first, and when there is not enough left, the bottom tranches get nothing.
Where did the sold loans end up?
Bloomberg data show that some loans sold out of Atlas CLO were subsequently repurchased by other CLOs managed by Crescent.
These include loans to software developer Ascend Learning (currently trading at about 99 cents) and healthcare-software provider AthenaHealth Group, which recently refinanced at near par.
In plain terms = the same manager sold assets at distressed-flag prices from one vehicle, then bought them back through another — same assets, different pocket. Crescent declined to comment.
How bad were the underlying assets?
Atlas CLO was issued in 2018 with a $510 million portfolio. Its life span ran straight through the retail downturn, COVID, and the 2022 rate-hiking cycle.
By June, the portfolio's average loan price had dropped from about 91 cents to about 83 cents in a single year; CCC-rated holdings kept climbing.
Troubled names include builder Cornerstone Building Brands (debt below 40 cents) and cybersecurity firm Ivanti (trading at roughly 32 cents).
Is this an isolated case or a systemic signal?
BofA CLO research head Pratik Gupta notes that single-B notes make up only 5% of total CLO issuance, yet 10–15% of them have experienced or are expected to experience impairment, with an average loss rate of about 50%.
Deutsche Bank data show that 2018-vintage CLOs account for roughly 32% of all BB-rated overcollateralization-test breaches — the core protective mechanism that, once tripped, redirects cash flow to senior bondholders.
This means → JPMorgan strategists report that deeply distressed U.S. leveraged loans (trading below 60 cents) have reached $65 billion, the highest since March 2020. Atlas CLO's wind-down is not a one-off — whether 2018-vintage CLOs can survive their remaining terms is an open question for the entire credit market.
市场有风险，内容仅供研究参考，不构成投资建议。